Dupixent

Sanofi and Regeneron’s Dupixent set for large gains with likely COPD approval

April 1, 2024

IvelinRadkov Sanofi (NASDAQ:SNY) and Regeneron Pharmaeuticals (NASDAQ:REGN) Dupixent (dupiliumab), already a blockbuster drug approved for several indications, including asthma and…

Johnson defends decision to attend Trump trial, calling the case ‘an atrocity’

Man charged after fleeing traffic stop with officer stuck in car in Dayton

5 ways to change your relationship with sugar

Leroy Seafood Group reports robust Q1 2024 results By Investing.com

Parallel Parenting: What Is It? Experts Weigh In

DeSantis Signs Bill Making Climate Change a Lesser Priority

The 14 Best Extra-Deep Sofas to Shop

Oil turns higher as U.S. inflation cools, crude stocks drop more than expected

North Carolina could ban face masks for medical reasons in public

NFL Responds to Harrison Butker's Controversial Graduation Speech

Dupixent

Sanofi and Regeneron’s Dupixent set for large gains with likely COPD approval

Johnson defends decision to attend Trump trial, calling the case ‘an atrocity’

Man charged after fleeing traffic stop with officer stuck in car in Dayton

5 ways to change your relationship with sugar

Leroy Seafood Group reports robust Q1 2024 results By Investing.com

Parallel Parenting: What Is It? Experts Weigh In

Johnson defends decision to attend Trump trial, calling the case ‘an atrocity’

U.S. postal worker among those indicted in $24 million check scheme

OpenAI investors push to reinstate Sam Altman as CEO

Biden orders top aides to prepare reprimands for violent Israeli settlers in West Bank

Colleen Ballinger Apologizes For 10-Minute Song Denying Grooming Allegations

Wisconsin gov, university condemn neo-Nazi march in Madison